ROCCI, LAURA

ROCCI, LAURA  

Mostra records
Risultati 1 - 18 di 18 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 1-gen-2007 Santini, D; Virzi, V; Vincenzi, B; Rocci, L; Leoni, V; Tonini, G
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 1-gen-2006 Vincenzi, B; Santini, D; Russo, A; Silletta, M; Gavasci, M; Battistoni, F; Di Cuonzo, G; Rocci, L; Gebbia, N; Tonini, G
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 1-gen-2003 Vincenzi, B; Santini, D; Rocci, L; Tonini, G
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 1-gen-2007 Vincenzi, B; Santini, D; Russo, A; Gavasci, M; Battistoni, F; Dicuonzo, G; Rocci, L; Rosaria, Vm; Gebbia, N; Tonini, G
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 1-gen-2005 Santini, D; Vincenzi, B; LA CESA, A; Caricato, M; Schiavon, G; Spalletta, B; DI SERI, M; Coppola, R; Rocci, L; Tonini, G.
Docetaxel induced pericardial effusion 1-gen-2007 Vincenzi, B; Santini, D; Frezza, Am; Rocci, L; Tonini, G
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 1-gen-2011 Vincenzi, B; Galluzzo, S; Santini, D; Rocci, L; Loupakis, F; Correale, P; Addeo, R; Zoccoli, A; Napolitano, A; Graziano, F; Ruzzo, A; Falcone, A; Francini, G; Dicuonzo, G; Tonini, G
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 1-gen-2008 Vincenzi, B; Santini, D; Galluzzo, S; Russo, A; Fulfaro, F; Silletta, M; Battistoni, F; Rocci, L; Beomonte Zobel, B; Adamo, V; Dicuonzo, G; Tonini, G
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 1-gen-2003 Tonini, G; Vincenzi, B; Di Cosimo, S; Gravante, G; Santini, D; Ambrogi, V; Micheletti, E; Rocci, L; D'Aprile, M
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 1-gen-2003 Dicuonzo, G; Vincenzi, B; Santini, D; Avvisati, G; Rocci, L; Battistoni, F; Gavasci, M; Borzomati, D; Coppola, R; Tonini, G
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 1-gen-2009 Santini, D; Martini, F; Fratto, Me; Galluzzo, S; Vincenzi, B; Agrati, C; Turchi, F; Piacentini, P; Rocci, L; Manavalan, Js; Tonini, G; Poccia, F
Meeting information needs on cancer-related fatigue: an exploration of views held by Italian patients and nurses 1-gen-2007 Piredda, M; De Marinis, M; Rocci, L; Gualandi, R; Tartaglini, D; Ream, E
Repeated intermittent low-dose therapy with zoledronic Acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients 1-gen-2007 Santini, D; Vincenzi, B; Galluzzo, S; Battistoni, F; Rocci, L; Venditti, O; Schiavon, G; Angeletti, S; Uzzalli, F; Caraglia, M; Dicuonzo, G; Tonini, G
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 1-gen-2003 Santini, D; Vincenzi, B; Massacesi, C; Picardi, A; Gentilucci, Uv; Esposito, V; Liuzzi, G; La Cesa, A; Rocci, L; Marcucci, F; Montesarchio, V; Groeger, Am; Bonsignori, M; Tonini, G; Baldi, A
Scientific Evidence for Non-Pharmacological Management of the Main Side-Effects of Antineoplastic Drugs in Colorectal Cancer Patients. [Evidenze scientifiche per la gestione non farmacologica dei principali effetti collaterali della terapia antineoplastica nei pazienti con cancro colon-rettale] 1-gen-2009 Gualandi, R; Piredda, M; Rocci, L; De Benedictis, A; Matarese, M; Tartaglini, D; DE MARINIS, MARIA GRAZIA
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 1-gen-2008 Piredda, M; Rocci, L; Gualandi, R; Petitti, T; Vincenzi, B; DE MARINIS, MARIA GRAZIA
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 1-gen-2003 Santini, D; Vincenzi, B; Dicuonzo, G; Avvisati, G; Massacesi, C; Battistoni, F; Gavasci, M; Rocci, L; Tirindelli, Mc; Altomare, V; Tocchini, M; Bonsignori, M; Tonini, G
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 1-gen-2005 Vincenzi, B; Santini, D; Dicuonzo, G; Battistoni, F; Gavasci, M; La Cesa, A; Grilli, C; Virzi, V; Gasparro, S; Rocci, L; Tonini, G